These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22818417)

  • 1. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
    Góra J; Stock M; Lütgendorf-Caucig C; Georg D
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):881-8. PubMed ID: 22818417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robustness against interfraction prostate movement in scanned ion beam radiation therapy.
    Jelen U; Ammazzalorso F; Chanrion MA; Gräf S; Zink K; Engenhart-Cabillic R; Wittig A
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e257-62. PubMed ID: 22677368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
    Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
    Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
    Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
    [No Abstract]   [Full Text] [Related]  

  • 6. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
    Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans.
    Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
    Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of accounting for interfractional CTV shape variations in PTV margins on prostate cancer radiation treatment plans.
    Hirose TA; Arimura H; Shibayama Y; Fukunaga JI; Ohga S
    Phys Med; 2018 Oct; 54():66-76. PubMed ID: 30337012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
    Bridges D; Kawamura H; Kanai T
    PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
    Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
    Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer.
    Tyagi N; Lewis JH; Yashar CM; Vo D; Jiang SB; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):273-80. PubMed ID: 21109360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical modeling of CTV motion and deformation for IMRT of early-stage rectal cancer.
    Bondar L; Intven M; Burbach JP; Budiarto E; Kleijnen JP; Philippens M; van Asselen B; Seravalli E; Reerink O; Raaymakers B
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):664-72. PubMed ID: 25151540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
    Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
    Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.